Dr. Michael Fagien

Dr. Ralph Nader is a board-certified clinical and nuclear cardiologist with over 35 years of experience in private practice. He earned his medical degree with distinction from Northwestern University in Chicago and completed his specialty training at Beth Israel Hospital of Harvard Medical School and the Hospital of the University of Pennsylvania. Dr. Nader is board certified in internal medicine, cardiovascular diseases, nuclear cardiology, and interventional cardiology. He is a Fellow of the American College of Cardiology (FACC), the American Society of Nuclear Cardiology (FASNC), and the Society for Cardiovascular Angiography and Interventions. Dedicated to preventive care, Dr. Nader emphasizes early detection and clinical management of cardiovascular disease to help patients avoid surgical intervention whenever possible. He brings decades of expertise in performing and interpreting a wide range of diagnostic and therapeutic cardiovascular procedures, with a particular focus on nuclear cardiology and cardiac PET imaging. Dr. Nader is passionate about empowering patients to live long, active lives through healthy lifestyle choices, supported by medical therapy and advanced technology when appropriate. Dr. Nader is highly rated in 15 conditions, according to our data. His clinical expertise encompasses Necrosis, End-Stage Renal Disease (ESRD), Angina, Mitral Valve Regurgitation, and Endoscopy. Dr. Nader is currently accepting new patients.

Lawrence Elgarresta is a Nuclear Medicine provider practicing medicine in Miami, Florida. Dr. Elgarresta is highly rated in 4 conditions, according to our data. His clinical expertise encompasses Lung Nodules, Gallbladder Disease, Squamous Cell Carcinoma of the Anal Canal (SCAC), and ALK-Positive Non-Small Cell Lung Cancer. Dr. Elgarresta is currently accepting new patients.

George Sfakianakis is a Nuclear Medicine provider practicing medicine in Miami, Florida. Dr. Sfakianakis is highly rated in 1 condition, according to our data. His clinical expertise encompasses ALK-Positive Non-Small Cell Lung Cancer, Melorheostosis with Osteopoikilosis, Melorheostosis, and Osteopenia.